Can talking it out ease PTSD in cancer patients during a pandemic?

NCT ID NCT04747249

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether monthly 45-minute psychological interviews over 6 months could reduce post-traumatic stress symptoms in cancer patients affected by the COVID-19 pandemic. It included 29 adults with solid tumors who had moderate to high PTSD symptoms. The goal was to see if this supportive therapy could lower stress, improve resilience, and enhance sleep and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

psychological support (monthly interviews)

What this could lead to

If it works, this could point toward a simple, supportive therapy to reduce PTSD and improve quality of life for cancer patients during health crises.

What could go wrong

This is a very small, completed study with only 29 participants and no control group, so results may not apply broadly. The intervention is brief and may not work for everyone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinoma COVID-19 post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Francois Baclesse

    Caen, France